West Family Investments’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$440K Sell
3,486
-1,235
-26% -$163K 0.13% 220
2026
Q1
$658K Sell
4,721
-7,641
-62% -$1.07M 0.23% 79
2025
Q4
$1.52M Hold
12,362
0.36% 54
2025
Q3
$1.37M Buy
12,362
+165
+1% +$18.8K 0.31% 66
2025
Q2
$1.35M Buy
12,197
+2,558
+27% +$272K 0.35% 56
2025
Q1
$1.08M Hold
9,639
0.41% 49
2024
Q4
$890K Sell
9,639
-165
-2% -$14.9K 0.31% 65
2024
Q3
$822K Buy
9,804
+50
+0.5% +$3.81K 0.28% 71
2024
Q2
$669K Sell
9,754
-1,227
-11% -$81.9K 0.2% 88
2024
Q1
$804K Buy
10,981
+101
+0.9% +$7.77K 0.25% 77
2023
Q4
$881K Sell
10,880
-503
-4% -$39.1K 0.3% 63
2023
Q3
$853K Sell
11,383
-504
-4% -$38.8K 0.3% 67
2023
Q2
$916K Buy
+11,887
New +$948K 0.36% 63
2023
Q1
Sell
-11,870
Closed -$1.02M 238
2022
Q4
$1.02M Sell
11,870
-830
-7% -$65.7K 0.35% 61
2022
Q3
$783K Buy
12,700
+1,981
+18% +$125K 0.33% 68
2022
Q2
$663K Buy
10,719
+6,144
+134% +$380K 0.26% 76
2022
Q1
$272K Sell
4,575
-9,440
-67% -$603K 0.08% 207
2021
Q4
$1.02M Sell
14,015
-2,939
-17% -$202K 0.28% 66
2021
Q3
$1.18M Buy
16,954
+3,659
+28% +$257K 0.31% 57
2021
Q2
$915K Buy
+13,295
New +$888K 0.25% 62

Other funds holding GILD

West Family Investments's GILD Position: Q2 2026 in Review

West Family Investments reduced its Gilead Sciences (GILD) stake by 26% in Q2 2026, selling an estimated $163K and leaving 3,486 shares worth $440K. The position accounts for 0.13% of the portfolio, ranked #220.

West Family Investments first reported a position in GILD in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.52M in Q4 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • West Family Investments held 3,486 shares of Gilead Sciences worth $440K as of Q2 2026.
  • West Family Investments sold 1,235 Gilead Sciences shares in Q2 2026, an estimated $163K.
  • Gilead Sciences made up 0.13% of West Family Investments's portfolio in Q2 2026, its #220 holding.
  • West Family Investments first reported a position in Gilead Sciences in Q2 2021 and has held it in 20 quarters since.
  • West Family Investments's Gilead Sciences position peaked at $1.52M in Q4 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on West Family Investments's 13F filing for Q2 2026, filed 10 Aug 2026.